ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 470

Crucial Involvement of Citrullinated Proteins and ACPA in the Development of Peptide-Glucose-6-Phosphate Isomerase Induced Arthritis

Hoshimi Kawaguchi1, Isao Matsumoto1, Hiroshi Ebe1, Naoto Umeda1, Yuya Kondo1, Hiroto Tsuboi2 and Takayuki Sumida1, 1Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 2Division of Clinical Immunology, Doctoral Programs in Clinical Science, Graduated School of Comprehensive Human Science, University of Tsukuba, Tsukuba, Japan

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: ACPA, Animal models, citrullination, PAD, rheumatoid arthritis (RA) and rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Rheumatoid Arthritis – Animal Models - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Various citrullinated proteins and anti-citrullinated protein antibodies (ACPA) are increased in patients with rheumatoid arthritis (RA). ACPA have high specificity for RA, and are the predictive factor of joint radiographic progression. It is considered that citrullinated proteins and ACPA may contribute to the development and progression of RA. However, the relevance in the course of arthritis development remains uncertain. In this study, we explored the pathogenic relevance of citrullinated proteins and ACPA in peptide glucose-6-phosphate isomerase (pGPI)-induced arthritis (pGIA) mice.

 

Methods: 1) The titers of anti-pGPI antibodies and ACPA in sera from pGIA mice were analyzed by ELISA.

2) Citrullinated protein expressions in joints, skins and lungs were examined by immunohistochemistry. The protein expressions in sera were examined by Western blot analysis.

3) Cl-amidine, the inhibitor of protein arginine deiminase (PAD), was injected intraperitoneally to pGIA mice. Clinical score, the titers of ACPA, citrullinated protein expressions, T cell response and the level of proinflammatory cytokines in sera were assessed.

Results: 1) The titers of anti-pGPI antibodies and ACPA in sera from pGIA mice were elevated from day14, and were significantly higher than those from control mice.

2) In immunohistochemistry, citrullinated proteins were detected in joints on day 14 and in skins on day 7 from pGIA mice, whereas not detected from control mice. In joints, citrullinated proteins were expressed in areas of synovial hyperplasia. In skins, these proteins were expressed in infiltrating inflammatory cells surrounding injected areas in subcutaneous tissues. In lungs, citrullinated proteins were not detected from pGIA or control mice. In sera, citrullinated protein was detected at approximately 120 kD on day 14 from pGIA mice, and significantly increased than control mice.

3) Cl-amidine treatment significantly decreased clinical and synovitis score. The titers of anti-pGPI antibodies and ACPA in sera were not significantly different, but tended to lower by Cl-amidine treatment. Citrullinated proteins in joints, skins and sera from treated mice were clearly decreased. The level of IL-6 in sera on day 14 was significantly decreased in Cl-amidine injected mice as compared with control mice, but pGPI-specific CD4+ T cell response was not changed.

Conclusion:

Citrullinated proteins and ACPA were increased in pGIA mice. Additionally, the inhibition of PAD decreased the expression of citrullinated proteins and the production of proinflammatory cytokines, resulting in the suppression of arthritis. These results suggested that PAD was involved in the pathogenesis and maintenance of autoimmune arthritis.


Disclosure: H. Kawaguchi, None; I. Matsumoto, None; H. Ebe, None; N. Umeda, None; Y. Kondo, None; H. Tsuboi, None; T. Sumida, None.

To cite this abstract in AMA style:

Kawaguchi H, Matsumoto I, Ebe H, Umeda N, Kondo Y, Tsuboi H, Sumida T. Crucial Involvement of Citrullinated Proteins and ACPA in the Development of Peptide-Glucose-6-Phosphate Isomerase Induced Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/crucial-involvement-of-citrullinated-proteins-and-acpa-in-the-development-of-peptide-glucose-6-phosphate-isomerase-induced-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/crucial-involvement-of-citrullinated-proteins-and-acpa-in-the-development-of-peptide-glucose-6-phosphate-isomerase-induced-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology